Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Paul Ausick | Jan 24, 2020 at 11:20 AM EST

Pot Grower Aphria Gets C$100 Million Strategic Investment

Canada-based marijuana grower Aphria announced Friday morning a strategic investment of C$100 million. The stock is getting beaten up based…

Chris Lange | Jan 23, 2020 at 1:35 PM EST

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.

Chris Lange | Jan 23, 2020 at 10:10 AM EST

This Biotech Could Make a Big Splash With the Coronavirus Scare

New research shows that several members of the coronavirus family are susceptible to inactivation via a system developed by biomedical…

Chris Lange | Jan 23, 2020 at 9:45 AM EST

Are Investors Overreacting to This Achromatopsia Study?

Applied Genetic Technologies' shares were crushed early on Thursday after the firm reported interim data from its midstage trial in…

Chris Lange | Jan 22, 2020 at 10:30 AM EST

Why This Cardiovascular Disease Study Could Be Huge

Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular…

Jon C. Ogg | Jan 22, 2020 at 10:20 AM EST

Some Great News for Potential Alzheimer’s Treatment

Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe…

Paul Ausick | Jan 22, 2020 at 7:40 AM EST

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

Health care giant Johnson & Johnson reported fourth-quarter and full-year 2019 results Wednesday morning. The company posted narrow beats and…

Chris Lange | Jan 21, 2020 at 1:00 PM EST

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As…

Jon C. Ogg | Jan 21, 2020 at 10:15 AM EST

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout…

Chris Lange | Jan 21, 2020 at 10:00 AM EST

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past…

Douglas A. McIntyre | Jan 21, 2020 at 6:15 AM EST

China Virus: A Black Swan?

Rarely does a disease spread fast enough and is labeled dangerous enough that it quickly gets the attention of the…

Chris Lange | Jan 18, 2020 at 8:45 AM EST

This Week’s Biggest Biotech Movers

This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of…

Chris Lange | Jan 17, 2020 at 9:45 AM EST

What’s Next for Durect After FDA Posimir Vote

Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.

Chris Lange | Jan 16, 2020 at 11:20 AM EST

Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?

Neon Therapeutics shares shot up on Thursday after the firm announced that it will be acquired by BioNTech. Are Neon…

Chris Lange | Jan 15, 2020 at 1:06 PM EST

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.

1 … 71 72 73 74 75 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Pot Grower Aphria Gets C$100 Million Strategic Investment

How Earnings Will Dictate Biotech Sector’s Fate in 2020

This Biotech Could Make a Big Splash With the Coronavirus Scare

Are Investors Overreacting to This Achromatopsia Study?

Why This Cardiovascular Disease Study Could Be Huge

Some Great News for Potential Alzheimer’s Treatment

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

China Virus: A Black Swan?

This Week’s Biggest Biotech Movers

What’s Next for Durect After FDA Posimir Vote

Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

Health and Healthcare Articles

All Health and Healthcare Articles

Pot Grower Aphria Gets C$100 Million Strategic Investment

How Earnings Will Dictate Biotech Sector’s Fate in 2020

This Biotech Could Make a Big Splash With the Coronavirus Scare

Are Investors Overreacting to This Achromatopsia Study?

Why This Cardiovascular Disease Study Could Be Huge

Some Great News for Potential Alzheimer’s Treatment

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

China Virus: A Black Swan?

This Week’s Biggest Biotech Movers

What’s Next for Durect After FDA Posimir Vote

Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal